Clinical Trial Update: An Epidemiological Study to Assess Iron Overload Using MRI in Patients With Transfusional Siderosis (TIMES Study) [Phase 4]

View source ↗

Summary

Phase 4 epidemiological study update evaluating MRI-based assessment of iron overload in patients with thalassemia (including NTDT), myelodysplastic syndrome, a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Myelodysplastic Syndrome
• Thalassemia

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Thalassemia, Non-transfusional-dependent Thalassemia (NTDT), Myeloplastic Dysplasia (MDS), Other Anemia | Phase 4 | Status: COMPLETED | Results posted: 2016-09-19